Armistice Capital LLC Has $501,000 Position in NLS Pharmaceutics Ltd. (NASDAQ:NLSP)

Armistice Capital LLC grew its stake in shares of NLS Pharmaceutics Ltd. (NASDAQ:NLSP) by 6.4% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,311,000 shares of the company’s stock after acquiring an additional 139,000 shares during the period. Armistice Capital LLC owned 19.62% of NLS Pharmaceutics worth $501,000 as of its most recent SEC filing.

NLS Pharmaceutics Trading Down 5.5 %

Shares of NASDAQ:NLSP opened at $0.13 on Friday. NLS Pharmaceutics Ltd. has a 1 year low of $0.11 and a 1 year high of $1.02. The business has a fifty day simple moving average of $0.17 and a 200 day simple moving average of $0.17.

About NLS Pharmaceutics

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).